Treatment-Resistant Candida auris Infections Spreading Through U.S. Hospitals, CDC Warns
At least 20 states have reported their first treatment-resistant C. auris infections since 2020, according to CDC researchers
At least 20 states have reported their first treatment-resistant C. auris infections since 2020, according to CDC researchers
Repeated problems with duodenoscopes and the risk of patient infections have led to industry-wide changes in their design.
Recalled Artificial Eye Ointment carries the same risk of bacterial contamination that resulted in recent Artificial Tears eye drops recall, FDA warns.
The report urges countries to address climate change, waste disposal problems and antibiotic overuse to prevent the further evolution of treatment-resistant superbugs.
Dozens of infections have been linked to the contaminated eye drops, including at least one death, and a growing number of Artificial Tears lawsuits and class action claims are being pursued
Consumers should stop using recalled Fabuloso multi-purpose cleaner, due to the risk of bacterial contamination that may pose a serious infection risk
Latino dialysis patients face a 40% increased risk of bloodstream infections than White patients, while the risk for Black patients is 10% higher.
The Artificial Tears eye drops recall follows at least 50 reports of severe infections, resulting in vision loss, hospitalizations and at least one death
CDC has received at least 50 reports of severe eye infections from EzriCare Artificial Tears, including vision loss and at least one death.
Standard duodenoscopes were three times as likely to have persistent microbial contamination when compared to duodenoscopes with disposable elevator caps